Trial · NCT03326063
Adverse events32
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 32
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Upper Respiratory Tract Infection/Sinusitis, Grade 2 | Respiratory, thoracic and mediastinal disorders | Placebo | 2 | 18 | 2 |
| other | Upper Respiratory Tract Infection/Sinusitis, Grade 2 | Respiratory, thoracic and mediastinal disorders | Ifetroban | 0 | 18 | 0 |
| other | Pregnant partner | Pregnancy, puerperium and perinatal conditions | Placebo | 1 | 18 | 1 |
| other | Pregnant partner | Pregnancy, puerperium and perinatal conditions | Ifetroban | 0 | 18 | 0 |
| other | Rash, maculo-papular, Grade 1 | Skin and subcutaneous tissue disorders | Placebo | 2 | 18 | 2 |
| other | Rash, maculo-papular, Grade 1 | Skin and subcutaneous tissue disorders | Ifetroban | 0 | 18 | 0 |
| other | Ear Pain, Grade 1 | Ear and labyrinth disorders | Placebo | 1 | 18 | 1 |
| other | Ear Pain, Grade 1 | Ear and labyrinth disorders | Ifetroban | 0 | 18 | 0 |
| other | Stomach Pain, Grade 1 | Gastrointestinal disorders | Placebo | 1 | 18 | 1 |
| other | Stomach Pain, Grade 1 | Gastrointestinal disorders | Ifetroban | 0 | 18 | 0 |
| other | Eye disorder- Stye, Grade 1 | Eye disorders | Placebo | 0 | 18 | 0 |
| other | Eye disorder- Stye, Grade 1 | Eye disorders | Ifetroban | 1 | 18 | 1 |
| other | Systemic reaction to aspirin challenge with extrapulmonary symptoms | Injury, poisoning and procedural complications | Placebo | 2 | 18 | 2 |
| other | Systemic reaction to aspirin challenge with extrapulmonary symptoms | Injury, poisoning and procedural complications | Ifetroban | 3 | 18 | 3 |
| other | Lung Infection (influenza B-related pneumonia), Grade 2 | Infections and infestations | Placebo | 0 | 18 | 0 |
| other | Lung Infection (influenza B-related pneumonia), Grade 2 | Infections and infestations | Ifetroban | 1 | 18 | 1 |
| other | Wheezing, Grade 1 | Respiratory, thoracic and mediastinal disorders | Placebo | 0 | 18 | 0 |
| other | Wheezing, Grade 1 | Respiratory, thoracic and mediastinal disorders | Ifetroban | 2 | 18 | 2 |
| other | Sinus disorder (bloody nose), Grade 1 | Blood and lymphatic system disorders | Placebo | 0 | 18 | 0 |
| other | Sinus disorder (bloody nose), Grade 1 | Blood and lymphatic system disorders | Ifetroban | 1 | 18 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03326063/events